COVID-19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients

Hematol Oncol. 2021 Dec;39(5):712-714. doi: 10.1002/hon.2916. Epub 2021 Aug 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology*
  • Antibody Formation / drug effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • COVID-19 / immunology*
  • COVID-19 / prevention & control
  • COVID-19 / virology
  • COVID-19 Vaccines / administration & dosage*
  • COVID-19 Vaccines / immunology
  • Female
  • Follow-Up Studies
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / blood
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
  • Leukemia, Lymphocytic, Chronic, B-Cell / virology
  • Male
  • Prognosis
  • SARS-CoV-2 / immunology*
  • Vaccination / methods*

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines